Total Liabilities for Cencora (COR)
According to Cencora's latest reported financial statements, the company's latest reported total liabilities is $76.27B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
COR
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$76.27B
YoY change
+12.9%
5Y CAGR
+10.7%
Peak year (2025)
$74.84B
Latest annual
$74.84B
Total Liabilities history chart for Cencora (COR) from 1994 to 2025
Total Liabilities history table for Cencora (COR) from 1994 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $74.84B | +12.9% | ||
| 2024 | $66.31B | +7.1% | ||
| 2023 | $61.89B | +9.6% | ||
| 2022 | $56.49B | -0.5% | ||
| 2021 | $56.75B | +25.8% | ||
| 2020 | $45.11B | +23.7% | ||
| 2019 | $36.47B | +4.3% | ||
| 2018 | $34.97B | +5.2% | ||
| 2017 | $33.25B | +5.5% | ||
| 2016 | $31.51B | +15.2% | ||
| 2015 | $27.35B | +39.7% | ||
| 2014 | $19.58B | +17.9% | ||
| 2013 | $16.60B | +27.8% | ||
| 2012 | $12.99B | +7.2% | ||
| 2011 | $12.12B | +5.5% | ||
| 2010 | $11.48B | +5.8% | ||
| 2009 | $10.86B | +14.2% | ||
| 2008 | $9.51B | +3.2% | ||
| 2007 | $9.21B | +6.6% | ||
| 2006 | $8.64B | +21.7% | ||
| 2005 | $7.10B | -2.9% | ||
| 2004 | $7.31B | -9.0% | ||
| 2003 | $8.03B | +1.7% | ||
| 2002 | $7.90B | +6.0% | ||
| 2001 | $7.45B | +242.5% | ||
| 2000 | $2.18B | +14.9% | ||
| 1999 | $1.89B | +28.3% | ||
| 1998 | $1.48B | -14.7% | ||
| 1997 | $1.73B | +41.3% | ||
| 1996 | $1.22B | +25.7% | ||
| 1995 | $974.40M | -3.7% | ||
| 1994 | $1.01B | — |
Total Liabilities values are taken from Cencora's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Cencora (COR) total liabilities totalled $74.84B – grew 12.9% year-over-year.
Over 2020–2025 (5 years), Cencora total liabilities expanded at a +10.7% compound annual rate, with the latest reading among the more recent periods of the dataset.
2025 marks the peak total liabilities at $74.84B, with the historical low of $974.40M recorded in 1995.
Cencora (COR) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $101.80B.
Cencora Total Liabilities by Year
Cencora Total Liabilities 2025: $74.84B
Cencora total liabilities in 2025 was $74.84B, grew 12.9% from 2024. This figure represents the highest annual value in the available history.
Cencora Total Liabilities 2024: $66.31B
Cencora total liabilities in 2024 was $66.31B, grew 7.1% from 2023.
Cencora Total Liabilities 2023: $61.89B
Cencora total liabilities in 2023 was $61.89B, grew 9.6% from 2022.
Cencora Total Liabilities 2022: $56.49B
Cencora total liabilities in 2022 was $56.49B, edged down 0.5% below 2021.
Cencora Total Liabilities 2021: $56.75B
Cencora total liabilities in 2021 was $56.75B.
See more financial history for Cencora (COR).
Sector peers — Total Liabilities
Companies in the same sector as Cencora, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is Cencora's total liabilities?
- Latest reported total liabilities for Cencora (COR) is $76.27B (period ending December 31, 2025).
How has Cencora total liabilities changed year-over-year?
- Cencora (COR) total liabilities changed +12.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Cencora total liabilities?
- Cencora (COR) total liabilities compound annual growth rate is +10.7% over the most recent 5 years available.
When did Cencora total liabilities hit its highest annual value?
- Cencora total liabilities reached its highest annual value of $74.84B in 2025.
What was Cencora total liabilities in 2024?
- Cencora (COR) total liabilities in 2024 was $66.31B.
What was Cencora total liabilities in 2025?
- Cencora (COR) total liabilities in 2025 was $74.84B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
COR Overview
Company profile, financial tools, and key metrics
COR Revenue Counter
Earns $10,330 every second. See per minute, hour, and day.
COR Earnings Counter
Earns $51.54 per second net profit. See per minute, hour, and day.
COR Economic Scale
Exceeds Portugal's GDP. Compare with world economies.
COR What If Invested
What if you had invested $1,000? See historical returns from any date.
COR How It Makes Money
Discover visual breakdown of $325.78B in revenue — where it comes from and where it goes.
COR Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
COR Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
COR Daily Price Character
Steady · 51.0% historical win rate (green days). Streaks & record days.
COR Buybacks
0.08% TTM buyback yield. Shareholder yield & SBC comparison.
COR Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
COR Dividend Profile
Yield: 0.74%. Safety: 6/8. See full history.
COR Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
COR Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.